Yüklüyor......
Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants
BACKGROUND: Retinopathy of prematurity (ROP) is a vision‐threatening disease of preterm neonates. The use of beta‐adrenergic blocking agents (beta‐blockers), which modulate the vasoproliferative retinal process, may reduce the progression of ROP or even reverse established ROP. OBJECTIVES: To determ...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2018
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494413/ https://ncbi.nlm.nih.gov/pubmed/29499081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011893.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|